×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
Mutual Fund Summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Ads
Sun Pharma's Halol unit: Observations are minor & could be remedied easily, says Nirmal Bang
Industry facing pricing & competition problems: Sun Pharma
Will continue to pursue inorganic growth in India & US: Torrent Pharma
Expect Rs 280-285 crore of topline in Sorbitol segment: Gulshan Polyols
Sun Pharma survives tax evasion charge on IPR transfer to foreign arm
No scope of US intervention in Indian pharma cos: Wockhardt
GST positive step for Indian industry, consumers: Dilip Shanghvi
ITI Reinsurance may kick off ops in October this year: Sources
Rollout of InfuSMART to begin with UK, Netherlands: Sun Pharma
Regulatory risks waning in pharma sector: IIFL
Lupin to see approvals after US FDA gives clean chit: Macquarie
Sun's psoriasis trial drug won't hit mkt before FY19: Analyst
Sun Pharma inks pact with ICGEB for dengue drug Cipa
Sun Pharma joins hands with ICMR for malaria eradication prog
Indian pharma cos need to step-up safeguards at plants: Handa
Pharma cos facing pricing pressure in US: PhillipCap
Elepsia drug more relevant to Sun Pharma: Phillipcap
Strides Arcolab to buy Aspen's generic biz in Australia
No plan to merge SPARC with Sun Pharma: Dilip Shanghvi
Sun Pharma to buy GSK's opiates business in Australia
Mineral-based projects will get sorted in 2 yrs: JSW Steel
Sun's margins may reduce to 30-32% post merger: Surajit Pal
Sun-Ranbaxy: Agency to monitor drug divestment, says CCI
Sun Pharma: Can the stock climb higher than all-time high?
Wyeth's claim on Protonix unjustified: Sun Pharma
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio